Nectar Lifesciences Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue has consistently grown over the last four quarters, indicating strong demand.
Latest net profit of ₹7.84 Crore shows significant recovery compared to ₹1.02 Crore last year.
Improved operating profit margin of 11.97% showcases better cost management.

NEGATIVES

Profit before tax dropped significantly to -₹96.75 Crore this quarter, indicating financial strain.
Revenue dipped in the latest quarter compared to previous quarter, signaling potential challenges.
High material cost percentage at 83.67% raises concerns over future profitability.

Field	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	397.96	452.17	441.38	359.30	428.10	454.98	430.69	280.67
Expenses	406.93	450.19	431.73	354.93	420.12	443.01	618.44	377.78
Operating Profit	-8.97	1.98	9.64	4.37	7.98	11.97	-187.74	-97.11
Other Income	10.61	0.48	1.47	0.55	0.69	0.57	0.08	0.35
Interest	20.52	24.84	24.16	19.98	19.81	17.12	17.67	18.70
Depreciation	15.31	15.37	14.70	15.46	15.55	15.61	15.77	16.52
Profit Before Tax	1.64	2.46	11.11	4.92	8.67	12.55	-187.67	-96.75
Tax	0.63	0.89	10.52	1.95	3.07	4.71	-57.58	-33.52
Net Profit	1.02	1.57	0.59	2.97	5.60	7.84	-130.09	-63.23
Eps in Rs	0.05	0.07	0.03	0.13	0.25	0.35	-5.80	-2.82